Chemoinformaics analysis of (2Z,6E)-2,6-Nonadienal
Molecular Weight | 138.21 | nRot | 5 |
Heavy Atom Molecular Weight | 124.098 | nRig | 18 |
Exact Molecular Weight | 138.104 | nRing | 0 |
Solubility: LogS | -3.008 | nHRing | 0 |
Solubility: LogP | 4.436 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 25.1671 |
nHD | 0 | BPOL | 14.9129 |
QED | 0.368 |
Synth | 3.485 |
Natural Product Likeliness | 0.454 |
NR-PPAR-gamma | 0.011 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.027 |
Pgp-sub | 0.867 |
HIA | 0.59 |
CACO-2 | -5.102 |
MDCK | 0.00000485 |
BBB | 0.305 |
PPB | 0.653898 |
VDSS | 1.139 |
FU | 0.477629 |
CYP1A2-inh | 0.007 |
CYP1A2-sub | 0.626 |
CYP2c19-inh | 0.033 |
CYP2c19-sub | 0.98 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.013 |
CYP2d6-inh | 0.725 |
CYP2d6-sub | 0.916 |
CYP3a4-inh | 0.031 |
CYP3a4-sub | 0.509 |
CL | 5.432 |
T12 | 0.068 |
hERG | 0.278 |
Ames | 0.006 |
ROA | 0.412 |
SkinSen | 0.968 |
Carcinogencity | 0.04 |
EI | 0.016 |
Respiratory | 0.938 |
NR-Aromatase | 0.029 |
Antiviral | No |
Prediction | 0.949148 |